Catherine M. Szyman - May 7, 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
May 7, 2021
Transactions value $
-$235,818
Form type
4
Date filed
5/7/2021, 06:32 PM
Next filing
May 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $75.5K +3.39K +10.95% $22.29 34.3K May 7, 2021 Direct F1
transaction EW Common Stock Sale -$311K -3.39K -9.87% $91.87 30.9K May 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -3.39K -49.85% $0.00 3.41K May 7, 2021 Common Stock 3.39K $22.29 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.